Diagnosis and management of non-cystic fibrosis bronchiectasis

被引：16

作者：

Macfarlane, Laura ^{[1
]}

Kumar, Kartik ^{[2
,3
,4
,5
]}

Scoones, Thomas ^{[6
]}

Jones, Andrew ^{[7
,8
]}

Loebinger, Michael R. ^{[5
,9
,10
]}

Lord, Robert ^{[7
,8
]}

机构：

[1] Wythenshawe Hosp, Resp Med & Gen Internal Med, Manchester, Lancs, England

[2] NIHR Imperial BRC Clin Res, Resp Med & Gen Internal Med, London, England

[3] NIHR Imperial BRC Clin Res, London, England

[4] Imperial Coll London, London, England

[5] Royal Brompton Hosp, London, England

[6] Wythenshawe Hosp, Resp Med, Manchester, Lancs, England

[7] Wythenshawe Hosp, Manchester, Lancs, England

[8] Univ Manchester, Manchester, Lancs, England

[9] Imperial Coll London, Resp Med, London, England

[10] Imperial Coll London, Pract Resp Med, London, England

来源：

CLINICAL MEDICINE | 2021年 / 21卷 / 06期

关键词：

bronchiectasis; Pseudomonas aeruginosa; airway clearance; non-tuberculous mycobacteria; macrolides;

D O I：

10.7861/clinmed.2021-0651

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease that is associated with significant morbidity. In this review, we outline how patients with bronchiectasis may present clinically and describe an approach to its diagnosis, including how to identify an underlying aetiology. We discuss the important considerations when treating either acute exacerbations or stable disease and provide an overview of the role of long-term antimicrobials, airway clearance methods and other supportive management.

引用

页码：E571 / E577

页数：7

共 50 条

[21] Cough in non-cystic fibrosis bronchiectasis
Kantar, Ahmad
Song, Woo-Jung
Bush, Andrew
Chatziparasidis, Grigorios
ERJ OPEN RESEARCH, 2024, 10 (06)
[22] Non-cystic fibrosis bronchiectasis Response
Murray, Maeve P.
Hill, Adam T.
CLINICAL MEDICINE, 2009, 9 (04) : 402 - 402
[23] Exacerbations in non-cystic fibrosis bronchiectasis
Sahnoun, Imen
Racil, Hajer
Hafaied, Safa
Bacha, Saoussen
Rouhou, Sana Cheikh
Chawech, Newel
Mhiri, Emna
Chabbou, Abdellatif
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[24] Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
Park, In Kwon
Olivier, Kenneth N.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (02) : 217 - 224
[25] Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis
ElMaraachli, Wael
Conrad, Douglas J.
Wang, Angela C. C.
CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 139 - +
[26] Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
Justo, Julie Ann
Danziger, Larry H.
Gotfried, Mark H.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2013, 7 (05) : 272 - 287
[27] Defining severity in non-cystic fibrosis bronchiectasis
Poppelwell, Lucy
Chalmers, James D.
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (02) : 249 - 262
[28] Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
Zo, Sungmin
Moon, Ji-Yong
Min, Kyung Hoon
Lee, Hyun
TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (04) : 440 - 450
[29] The Bacterial Community in Non-Cystic Fibrosis Bronchiectasis
Parrish, S.
Nations, J. A.
Quast, T.
Lazarus, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[30] Brazilian consensus on non-cystic fibrosis bronchiectasis
Pereira, Monica Corso
Athanazio, Rodrigo Abensur
Roth Dalcin, Paulo de Tarso
Fernandes de Figueiredo, Mara Rubia
Gomes, Mauro
de Freitas, Clarice Guimaraes
Ludgren, Fernando
Paschoal, Ilma Aparecida
Rached, Samia Zahi
Maurici, Rosemeri
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2019, 45 (04)

← 1 2 3 4 5 →